Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]

M Loutfy; E Ribera; E Florence; S De Wit; A Castagna; R Ryan; A Hill; H Vanaken; Y van Delft; S Marks

Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]

M Loutfy, E Ribera, E Florence, S De Wit, A Castagna, R Ryan, A Hill, H Vanaken, Y van Delft, S Marks

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Journal of Antimicrobial Chemotherapy
Volume	64
Issue number	6
Pages (from-to)	1341-1344
Number of pages	4
ISSN	0305-7453
Publication status	Published - 2009

Keywords

B780-tropical-medicine
Viral diseases
HIV
Drug therapy
Reverse transcriptase inhibitors
Non-nucleoside
Fusion inhibitors
Enfuvirtide
Etravirine
CD4 lymphocyte count
RNA suppression
Tolerability
Convenience
Clinical trials

Access to Document

Cite this

@article{9eab7909c98c4991bc053193c0e81b01,

title = "Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]",

keywords = "B780-tropical-medicine, Viral diseases, HIV, Drug therapy, Reverse transcriptase inhibitors, Non-nucleoside, Fusion inhibitors, Enfuvirtide, Etravirine, CD4 lymphocyte count, RNA suppression, Tolerability, Convenience, Clinical trials",

author = "M Loutfy and E Ribera and E Florence and {De Wit}, S and A Castagna and R Ryan and A Hill and H Vanaken and {van Delft}, Y and S Marks",

note = "ITG-C3A; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE",

year = "2009",

language = "English",

volume = "64",

pages = "1341--1344",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "6",

}

Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]. / Loutfy, M; Ribera, E; Florence, E; De Wit, S; Castagna, A; Ryan, R; Hill, A; Vanaken, H; van Delft, Y; Marks, S.

In: Journal of Antimicrobial Chemotherapy, Vol. 64, No. 6, 2009, p. 1341-1344.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter]

AU - Loutfy, M

AU - Ribera, E

AU - Florence, E

AU - De Wit, S

AU - Castagna, A

AU - Ryan, R

AU - Hill, A

AU - Vanaken, H

AU - van Delft, Y

AU - Marks, S

N1 - ITG-C3A; CLINIC; U-HIVCLI; JIF; DOI; PDF; DSPACE

PY - 2009

Y1 - 2009

KW - B780-tropical-medicine

KW - Viral diseases

KW - HIV

KW - Drug therapy

KW - Reverse transcriptase inhibitors

KW - Non-nucleoside

KW - Fusion inhibitors

KW - Enfuvirtide

KW - Etravirine

KW - CD4 lymphocyte count

KW - RNA suppression

KW - Tolerability

KW - Convenience

KW - Clinical trials

M3 - Letter

VL - 64

SP - 1341

EP - 1344

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 6

ER -